The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

HeartFlow’s $364m initial public offering (IPO) signals market validation for the use artificial intelligence (AI) in a ...

Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

Heartflow has priced its previously announced initial public offering (IPO), with proceeds potentially reaching up to $300 ...

Backed by Bain Capital, the health technology startup makes 3D models of people's hearts to help diagnose diseases. Here's ...

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...

Heartflow announced today that it closed its upsized initial public offering (IPO) with proceeds totaling approximately $364.2 million.

Heartflow (NASDAQ: HTFL) stock surges ~50% as the company focused on AI-driven tools for the diagnosis of heart diseases make ...

The Bain Capital-backed company's debut comes as expectations of a softer trade policy and lower interest rates boost ...

Heartflow (HTFL) on Thursday announced the pricing of its upsized initial public offering of 16,666,667 shares of its common stock at a public offering price of $19.00 per share.

Heartflow has pumped up its IPO ambitions, raising its proposal into the vicinity of $300 million. | After first pricing its offering earlier this month, the AI-powered coronary diagnostic developer ...